Form 483

Universal Packaging Systems, Inc. Form 483, 2025-05-29

FDA issued a Form 483 to Universal Packaging Systems, Inc. on 2025-05-29 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

Universal Packaging Systems, Inc. · Chino, United States · Issued May 29, 2025

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

29 May 2025
21 CFR 211.100(b)

SOPs not followed / documented

Cited by Darren S Brown, Navneet Kaur, Ngozi G Offor

29 May 2025
21 CFR 211.142

Written warehousing procedures established/followed

Cited by Darren S Brown, Navneet Kaur, Ngozi G Offor

29 May 2025
21 CFR 211.166(a)(2)

Stability sample storage conditions described

Cited by Darren S Brown, Navneet Kaur, Ngozi G Offor

29 May 2025
21 CFR 211.166(a)(3)

Valid stability test methods

Cited by Darren S Brown, Navneet Kaur, Ngozi G Offor

29 May 2025
21 CFR 211.22(a)

Approve or reject components, products

Cited by Darren S Brown, Navneet Kaur, Ngozi G Offor

Inspected site

UPUniversal Packaging Systems, Inc.Chino, United States

Inspection team

DSDarren S Brown
NKNavneet Kaur

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.142Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.22(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere

Related Form 483s